SCHEMBL19249159

SCHEMBL19249159

O=c1cc(CNCl)[nH]c2ccc(C#Cc3ccccc3)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 4/20 0.45
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
ADRB2 P07550 1/20 0.45
CHRM2 P08172 1/20 0.45
ADRB1 P08588 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
CHRM1 P11229 1/20 0.45
DRD2 P14416 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
CHRM3 P20309 1/20 0.45
DRD1 P21728 1/20 0.45
DRD5 P21918 1/20 0.45
HRH2 P25021 1/20 0.45
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19211183 0.83 ASIC3 (0.42) DRD4GRIN2DGRIN3BADRB2CHRM2
Hydrochloric Acid SCHEMBL19211215 0.82 ASIC3 (0.41) DRD4GRIN2DGRIN3BADRB2CHRM2
SCHEMBL19248871 0.77 DRD4 (0.50) DRD4GRIN2DGRIN3BADRB2CHRM2
SCHEMBL19249246 0.72 GHSR (0.61) DRD4GRIN2DGRIN3BADRB2CHRM2
SCHEMBL19211279 0.71 GHSR (0.46) DRD4GRM5ALDH1A1CTSVCTSL
SCHEMBL19211285 0.71 GRM5 (0.45) DRD4GRM5ALDH1A1MEN1KMT2A
SCHEMBL19211219 0.70 GABRA1 (0.47) DRD4GRIN2DGRIN3BADRB2CHRM2
SCHEMBL19211211 0.69 DRD4 (0.42) DRD4GRIN2DGRIN3BADRB2CHRM2
SCHEMBL19211213 0.69 GRM5 (0.47) DRD4GRIN2DGRIN3BADRB2CHRM2
SCHEMBL19249206 0.68 DRD4 (0.39) DRD4GRIN2DGRIN3BADRB2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017139274-A1 QUINOLINONE LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. (US) 2017-08-17 WO disclosed